Candel Therapeutics Inc. (CADL)
NASDAQ: CADL
· Real-Time Price · USD
6.05
0.01 (0.17%)
At close: Aug 15, 2025, 3:59 PM
6.10
0.74%
After-hours: Aug 15, 2025, 07:51 PM EDT
Candel Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 1.78M | n/a | n/a | n/a | 31K | 31K | 31K | 31K | 31K | 31K | 31K | 31K |
Cost of Revenue | n/a | n/a | n/a | 249K | 251K | 312K | 306K | 295K | n/a | 276K | 258K | 238K | 215K | 178K | 5.26M | 3.29M | 2.75M |
Gross Profit | n/a | n/a | n/a | -249K | -251K | 1.46M | -306K | -295K | n/a | -245K | -227K | -207K | -184K | -147K | -5.23M | -3.26M | -2.72M |
Operating Income | -8.13M | -8.14M | -8.76M | -8.57M | -7.9M | -10.32M | -8.86M | -9.58M | -9.63M | -8.1M | -8.88M | -8.75M | -8.99M | -7.74M | -8.03M | -5.3M | -4.66M |
Interest Income | 934K | 290K | 236K | 240K | 320K | 415K | 502K | 453K | 711K | n/a | 343K | 70K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 7.38M | -14.07M | -10.65M | -22.24M | -8.22M | -11.1M | -8.44M | -9.61M | -8.79M | -5.08M | -8.69M | -4.15M | -874K | 1.6M | -16.16M | -17.08M | -4.48M |
Net Income | 7.38M | -14.07M | -10.65M | -22.24M | -8.22M | -11.1M | -8.44M | -9.61M | -8.79M | 10.65M | -8.49M | 455K | 7.24M | 1.6M | -16.16M | -17.08M | -4.48M |
Selling & General & Admin | 4.11M | 3.32M | 3.34M | 3.59M | 3.8M | 3.06M | 3.02M | 3.65M | 4.16M | 3.16M | 3.54M | 3.76M | 3.6M | 3.92M | 2.79M | 2.04M | 1.94M |
Research & Development | 4.02M | 4.82M | 5.42M | 4.98M | 3.85M | 6.95M | 5.84M | 5.93M | 5.47M | 4.97M | 5.38M | 5.02M | 5.42M | 3.85M | 5.26M | 3.29M | 2.75M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 12K | n/a | n/a | n/a | -48K | 5.34M | 4.99M | 5.39M | 15.98M | -8.25M | -12.37M | -191K |
Operating Expenses | 8.13M | 8.14M | 8.76M | 8.57M | 7.65M | 10.01M | 8.86M | 9.57M | 9.63M | 8.08M | 8.91M | 8.78M | 9.02M | 7.62M | 7.93M | 4.73M | 4.5M |
Interest Expense | 306K | 390K | 487K | 567K | 646K | 673K | 669K | 644K | 609K | 666K | 519K | 435K | 175K | 11K | 14K | 15K | 12K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 8.89M | 8.76M | 8.57M | 7.9M | 10.32M | 8.86M | 9.57M | 9.63M | 8.08M | 8.91M | 8.78M | 9.02M | 7.62M | 7.93M | 4.73M | 4.5M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15.73M | -193K | -4.6M | -8.11M | 12K | 14K | 15K | n/a |
Shares Outstanding (Basic) | 31.68M | 35.56M | 32.01M | 29.88M | 29.2M | 28.98M | 28.92M | 28.92M | 28.92M | 28.9M | 28.89M | 28.81M | 28.69M | 23.33M | 23.33M | 24.8M | 18.71M |
Shares Outstanding (Diluted) | 31.68M | 35.56M | 32.01M | 29.88M | 29.2M | 28.98M | 28.92M | 28.92M | 28.92M | 28.9M | 28.89M | 28.81M | 28.69M | 23.33M | 23.33M | 24.8M | 18.71M |
EPS (Basic) | 0.23 | -0.44 | -0.33 | -0.74 | -0.28 | -0.38 | -0.29 | -0.33 | -0.3 | 0.37 | -0.29 | 0.02 | 0.25 | 0.07 | -0.69 | -0.69 | -0.24 |
EPS (Diluted) | 0.23 | -0.44 | -0.33 | -0.74 | -0.28 | -0.38 | -0.29 | -0.33 | -0.3 | 0.37 | -0.29 | 0.02 | 0.25 | 0.07 | -0.69 | -0.69 | -0.24 |
EBITDA | -8.13M | -13.44M | -9.91M | -21.42M | -7.32M | -10.11M | -7.46M | -8.68M | -7.96M | -7.88M | -8.25M | -3.55M | -8.82M | 1.78M | -8.03M | -5.3M | -4.44M |
EBIT | n/a | -13.68M | -10.16M | -21.67M | -7.58M | -10.42M | -7.77M | -8.97M | -8.19M | -8.1M | -8.51M | -3.78M | -8.99M | 1.61M | -8.03M | -5.3M | -4.47M |
Depreciation & Amortization | n/a | 245K | 245K | 249K | 251K | 312K | 306K | 295K | 230K | 276K | 258K | 238K | 215K | 178K | 22K | 21K | 26K |